Animal models of human type 1 diabetes for evaluating combination therapies and successful translation to the patient with type 1 diabetes

@article{Lenzen2017AnimalMO,
  title={Animal models of human type 1 diabetes for evaluating combination therapies and successful translation to the patient with type 1 diabetes},
  author={Sigurd Lenzen},
  journal={Diabetes/Metabolism Research and Reviews},
  year={2017},
  volume={33}
}
  • S. Lenzen
  • Published 1 October 2017
  • Medicine, Biology
  • Diabetes/Metabolism Research and Reviews
Animal models of human type 1 diabetes will be of a great importance for the evaluation of new combination therapies with curative potential. However, reliable predictive power for successful translation to patients with type 1 diabetes is crucial. This will be particularly important in the future when evaluating success of new combination therapies that show great promise for preservation and restoration of beta cell mass and thereby reverse the type 1 diabetic hyperglycaemia. But not all… 

Rat Models of Human Type 1 Diabetes.

TLDR
For all three established rat models, a distinctive genetic mutation has been identified that is responsible for the manifestation of the diabetic syndrome in these rat strains.

Animal Models of Diabetes: Methods and Protocols

TLDR
This chapter outlines common variables that can impact the phenotype of a model, as well as describes the methods used for assessing onset of diabetes and monitoring diabetic mice.

Mouse Models of Virus-Induced Type 1 Diabetes.

TLDR
This chapter describes two robust and clinically relevant mouse models for virus-induced type 1 diabetes; acceleration of disease onset in prediabetic nonobese diabetic (NOD) mice following Coxsackievirus infection and diabetes induction by lymphocytic choriomeningitis virus infection of transgenic mice expressing viral neo-antigens under control of the rat insulin promoter (RIP).

Translation of curative therapy concepts with T cell and cytokine antibody combinations for type 1 diabetes reversal in the IDDM rat

TLDR
The double antibody combination of anti-TCR with anti-TNF-α proved to be the most suited therapy for reversal of the T1D metabolic state due to effective beta cell regeneration in an infiltration free pancreas.

An editorial on the article ‘Patents in the Diabetes Area in the Years 2008-2016’

  • S. Lenzen
  • Medicine
    Expert opinion on therapeutic patents
  • 2018
TLDR
There is a need for further active research and development of new better treatment options for patients with type 2 diabetes, and metformin is still the drug of first choice, alone or in combination.

Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargement

TLDR
The presence and extent of bladder enlargement vary markedly across diabetes models, particularly type 2 diabetes models; the data do not support the idea that bladder enlargements is primarily driven by glucose levels/glucosuria.

Streptozotocin‐Induced Diabetic Models in Mice and Rats

  • B. Furman
  • Biology
    Current protocols in pharmacology
  • 2015
TLDR
Protocols for producing STZ‐induced insulin deficiency and hyperglycemia in mice and rats and creating animal models for type 2 diabetes using STZ are described.

Streptozotocin‐Induced Diabetic Models in Mice and Rats

TLDR
Protocols for producing STZ‐induced insulin deficiency and hyperglycemia in mice and rats and creating animal models for type 2 diabetes using STZ are described.

Hypoglycaemia: Still the main drawback of insulin 100 years on: “From man to mouse”

TLDR
From its origin in dogs, insulin treatment has revolutionised the lives of those with Type 1 diabetes through the coordinated effort of scientists and clinicians and in this review, the more recent research that uses a mouse‐to‐man approach in hypoglycaemia research is recounted.

References

SHOWING 1-10 OF 37 REFERENCES

The use of animal models in diabetes research

  • Aileen King
  • Medicine, Biology
    British journal of pharmacology
  • 2012
TLDR
Some of the models currently used in diabetes research are outlined, including transgenic and knock‐out mouse models, which range from animals with spontaneously developing autoimmune diabetes to chemical ablation of the pancreatic beta cells.

Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes

TLDR
A combination of approved drugs demonstrates a novel ability to reverse T1D, thereby warranting translational consideration and allowing for effective treatment at reduced drug doses, thereby minimizing potential adverse effects while retaining efficacy.

Are Insights Gained from NOD Mice Sufficient to Guide Clinical Translation?

  • B. Roep
  • Biology, Medicine
    Annals of the New York Academy of Sciences
  • 2007
TLDR
It is argued that animal models have limited but evident value when it comes to teaching us about type 1 diabetes in humans, and the authors can take advantage of this value more efficiently.

Experimental Diabetes Mellitus in Different Animal Models

TLDR
The pathophysiological features of diabetes in relation to its complications in type 1 and type 2 mice along with rat models are overviewed along with the challenges associated with the evaluation and predictive validation of these models as ideal animal models for preclinical assessments and discovering new drugs and therapeutic agents for translational application in humans.

Rat models of type 1 diabetes: genetics, environment, and autoimmunity.

TLDR
Data generated in the rat have correctly predicted the outcome of several human diabetes prevention trials, notably the failure of nicotinamide and low dose parenteral and oral insulin therapies.

Combination immunotherapies for type 1 diabetes mellitus

TLDR
Novel promising combination therapies are being developed, including those that couple immunomodulators with drugs that stimulate β-cell regeneration in order to restore normoglycaemia, an encouraging one to pursue the goal of finding a cure for T1DM.

The NOD mouse model of type 1 diabetes: As good as it gets?

TLDR
The authors re-examine the value of this mouse model as a tool for understanding human diabetes and for testing potential therapies, reviewing both strengths and weaknesses.

Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN–JDRF Type 1 Diabetes Combination Therapy Assessment Group

TLDR
A Type 1 Diabetes Combination Therapy Assessment Group was convened and the recommendations, the recommendations of which are discussed in this Perspective paper, are discussed.